Omalizumab and changes in airway hyperresponsiveness.
Currie
Graeme P
GP
Saha
Sudip
S
Lee
Daniel K C
DK
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D016535:Bronchial Hyperreactivity; D001985:Bronchial Provocation Tests; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D007249:Inflammation; D016210:Methacholine Chloride; D000069444:Omalizumab
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D016210:Methacholine Chloride; D000069444:Omalizumab; D007073:Immunoglobulin E